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https://doi.org/10.1016/j.stemcr.2017.10.023SUMMARYHuman pluripotent stem cells (hPSCs) are widely used to study cardiovascular cell differentiation and function. Here, we induced differ-
entiation of hPSCs (both embryonic and induced) to proepicardial/epicardial progenitor cells that cover the heart during development.
Addition of retinoic acid (RA) and bone morphogenetic protein 4 (BMP4) promoted expression of the mesodermal marker PDGFRa, up-
regulated characteristic (pro)epicardial progenitor cell genes, and downregulated transcription of myocardial genes. We confirmed the
(pro)epicardial-like properties of these cells using in vitro co-culture assays and in ovo grafting of hPSC-epicardial cells into chick embryos.
Our data show that RA + BMP4-treated hPSCs differentiate into (pro)epicardial-like cells displaying functional properties (adhesion and
spreading over themyocardium) of their in vivo counterpart. The results extend evidence that hPSCs are an excellentmodel to study (pro)
epicardial differentiation into cardiovascular cells in human development and evaluate their potential for cardiac regeneration.INTRODUCTION
Mature muscle cells in the mammalian heart proliferate
very slowly limiting its regenerative capacity after injury.
Accordingly, cardiomyocytes dying after infarction are
not replaced by new ones but instead characteristic fibrotic
scar tissue forms, which interferes with potential cardio-
myocyte regeneration, impairs heart function, and may
later result in heart failure (Jessup and Brozena, 2003).
Therefore, to regenerate the injured heart, exogenous
or endogenous cardiomyocytes are needed to replace
those lost.
Multiple cell-based strategies to regenerate damaged
post-mitotic tissues have been described (reviewed by Pass-
ier et al., 2008). Human pluripotent stem cells (hPSCs) are
also considered a potential source of cardiomyocytes for
transplantation strategies and are already an excellent
in vitro model to study the complex transcriptional net-
works and molecular interactions that regulate cardiomyo-
genesis (Beqqali et al., 2006; Birket and Mummery, 2015).
Recently, epicardial-derived cells have also emerged as a
source of various cardiovascular cell types, including
endothelial cells, smooth muscle cells, and fibroblasts
(Brade et al., 2013). However, in vivo cardiomyocyte forma-
tion from epicardial cells remains controversial (Christof-
fels et al., 2009).
During embryogenesis, proepicardial (epicardial progen-
itor) cells form the epicardium (the monolayer of epithe-1754 Stem Cell Reports j Vol. 9 j 1754–1764 j December 12, 2017 j ª 2017
This is an open access article under the CC BY-NC-ND license (http://creativlium that covers the heart surface), part of the coronary
vasculature, and a heterogeneous population of non-
muscular cardiac interstitial cells (CICs) (Pérez-Pomares
and de la Pompa, 2011; Ruiz-Villalba et al., 2015). Among
epicardial-derived CICs, a platelet-derived growth factor re-
ceptor a-positive (Pdgfra+) cell subpopulation has been
identified in mice, which displays cardiac stem cell proper-
ties and is able to expand clonally and differentiate into
endothelial and smoothmuscle cells, fibroblasts, and cardi-
omyocytes (Chong et al., 2011). A recent study indicated
that CICs include a population of cardiac fibroblast progen-
itors, whichmassively expand after ischemic damage (Ruiz-
Villalba et al., 2015). Therefore, modulation of epicardial
cell differentiation into different cardiac cell types might
be highly relevant in developing cell-based strategies for
heart repair.
Several studies have identified some of the relevant cues
that regulate cardiomyocyte differentiation and diversifica-
tion. Among these, retinoic acid (RA) (Devalla et al., 2015;
Niederreither et al., 2001) and bone morphogenetic pro-
tein 4 (BMP4) (Van Wijk et al., 2009) have been shown to
be important in specification of cardiac inflow cardiomyo-
cyte differentiation. Other signals, most especially WNTs,
have also been involved in the regulation of cardiomyocyte
differentiation (Klaus et al., 2012), but their role during
early cardiogenesis remains elusive, probably due to
cardiomyocyte progenitor sensitivity to WNT dose and
the complexity of WNT signaling redundancy (GrigoryanThe Authors.
ecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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et al., 2008). Nevertheless, two recent reports have success-
fully linked in vivo information on development to an
in vitro hPSC model and demonstrated epicardial-like cell
differentiation from human embryonic stem cells (hESCs)
by modulating WNT and BMP signaling (Iyer et al., 2015;
Witty et al., 2014). Here, we have extended and comple-
mented these studies by identifying developmentally rele-
vant transitional stages between lateral plate mesoderm
and the embryonic epicardium in vitro. In particular, we
have focused on the proepicardial stage, at which cardiac
inflow cardiomyocytes and fibroblasts segregate from a
common progenitor in response to integrated BMP4 and
fibroblast growth factor 2 signals, resulting in the loss of
cardiomyocyte differentiation potential in primitive
epicardial cells (Van Wijk et al., 2009).
To study mesodermal specification into the epicardial
lineage while monitoring cardiomyogenic potential, we
used a transgenic NKX2-5EGFP/w hESC line in which GFP
transcription is under control of the endogenous myocar-
diogenic transcription factor NKX2-5 (Elliott et al., 2011),
with RA, BMP4, and RA + BMP4 at previously tested con-
centrations (Devalla et al., 2015; reviewed in Birket and
Mummery, 2015). We found that epicardial cell-like differ-
entiation in the presence of RA + BMP4 was at the expense
of cardiomyocyte formation, as demonstrated by the fail-
ure to express GFP, which was also confirmed in human
induced pluripotent stem cells (hiPSCs). Since WNT
signaling disruption after b-catenin ablation in the proepi-
cardium/epicardium does not affect proepicardial or
epicardial formation, but rather affects epicardial differen-
tiation into coronary blood vessel cells (Zamora et al.,
2007), and WNTs appeared dispensable for epicardial dif-
ferentiation of hESCs in an earlier study (Iyer et al.,
2015), we did not include WNT in our protocols.
Our findings indicated that BMP4 and RA synergisti-
cally induce hPSC differentiation into proepicardial/
epicardial cells by blocking cardiomyocyte differentia-
tion and promoting proepicardium-specific gene expres-
sion. The hPSC-derived epicardial progenitor cells
showed similar adhesion and migration properties as em-
bryonic proepicardium, most strikingly when graftedFigure 1. RA + BMP4 Synergistically Promote Proepicardial Cell D
(A) NKX2-5EGFP/w hESCs differentiate into GFP+-bearing embryoid bod
(B) Culture supplements are indicated as related to specific protocols
(C) Average percentages (n = 7 independent experiments) of GFP
mean ± SD (ns, non-significant; *p < 0.05; **p < 0.01; ***p < 0.001
(D) Representative FACS plots depicting GFP+ and PDGFRa+ cell perce
(E) qRT-PCR validation of cardiac versus proepicardial-like gene expre
experiments). Data are presented as mean ± SD (ns, non-significant;
(F) qRT-PCR validation of cardiac versus proepicardial-like gene expre
independent experiments). Data represent mean ± SEM (all differe
100 mm in (A).
1756 Stem Cell Reports j Vol. 9 j 1754–1764 j December 12, 2017into the prospective pericardial cavity of chick embryos.
This demonstrated their functional integrity as a model
for further understanding of the epicardium in the hu-
man heart.RESULTS AND DISCUSSION
RA + BMP4 Synergistically Promote NKX2-5EGFP/w
hESCs Differentiation into Proepicardial-like Cells in
the Absence of Exogenous WNTs
Previously, various cytokines and small molecules have
been used sequentially to initiate cardiac differentiation
of NKX2-5EGFP/w hESCs cultured as aggregates/embryoid
bodies (EBs) (Elliott et al., 2011). Under these conditions,
NKX2-5EGFP/w hESCs robustly differentiate into cardiomyo-
cytes after 9–10 days in culture (Figure 1A). To test whether
NKX2-5EGFP/w hESCs differentiate into proepicardial-like
cells, we modified this protocol by adding BMP4 and RA
at different time points (Figure 1B).
Morphologically, BMP4- and/or RA-treated EBs (proto-
cols 2–4) were similar to control EBs (protocol 1) (data
not shown). However, adding BMP4 and/or RA on days 3
and 4 (protocols 2–4) increased the appearance of cells ex-
pressing the mesodermal/epicardial marker PDGFRa (Gua-
dix et al., 2011; Hwang et al., 2013) in GFPNKX2-5EGFP/w
hESCs, as assessed by fluorescence-activated cell sorting
(FACS) analysis at day 9 (Figure 1C); this effect was greatest
after protocol 4 (RA + BMP4) (Figures 1C–1E). Quantifica-
tion of GFP+ cells in each of the four treatments (day 9)
confirmed a significant decrease (but not abrogation) of
NKX2-5EGFP/w hESC differentiation into GFP+ cardiomyo-
cytes after protocol 4 (RA + BMP4; Figures 1C and 1D).
Gene expression analysis of cells emerging from protocols
2 and 3 (Figure 1B) indicated that RA alone induced a
small increase in epicardial/proepicardial-associated genes
such as WT1, TCF21, and TBX18, while robustly suppress-
ing cardiomyocyte-associated genes such as NKX2-5 and
a-ACTININ (Figure 1E). Thus, RA is not only able to activate
epicardial/proepicardial genes, but is also sufficient to
suppress NKX2-5 and cardiac a-ACTININ expression. Inifferentiation from NKX2-5EGFP/w hESCs
ies (EBs) after protocol 1 (B).
.
and PDGFRa+ FACS analyzed cells (culture day 9). Data represent
).
ntages after protocols 1–4 (culture day 9).
ssion in hESCs after protocols 1–4 (culture day 9, n = 4 independent
*p < 0.05; **p < 0.01).
ssion in hPSCs after monolayer differentiation (culture day 9, n = 3
nces between groups are non-significant, p < 0.05). Scale bars,
(legend on next page)
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accordance with these results, RA signaling in zebrafish
anterior lateral plate mesoderm has also been shown to
restrict the size of the cardiac progenitor pool (Keegan
et al., 2005). These findings suggested that RA-dependent
cardiac differentiation from hESC in vitro recapitulated
development in vivo (Niederreither et al., 2001). Interest-
ingly, BMP4, as compared with RA, increased epicardial/
proepicardial gene expression (WT1, TCF21, and TBX18),
but did not reduce the expression of cardiomyocyte genes
NKX2-5 and a-ACTININ (Figure 1E). The combination
of BMP4 and RA further increased the expression of epicar-
dial/proepicardial genes, such asWT1, TCF21, and TBX18,
while efficiently reducing the expression of NKX2-5 and
a-ACTININ (Figure 1E) in 9 days only (for comparison,
the previously reported WNT3 + BMP4 combination pro-
moted epicardial differentiation in 15 days, Witty et al.,
2014). These results indicated that BMP4 and RA synergis-
tically activate an ‘‘epicardial lineage-like’’ gene program at
the expense of cardiomyocyte differentiation, but without
fully abrogating cardiomyocyte (Figure 1D) or endothelial
cell differentiation in culture (data not shown). In our pro-
tocol, EBs were supplemented with BMP4 from day 3, and
with RA + BMP4 from days 4 to 9, i.e., during the temporal
window marked by the transient expression of the cardiac
mesoderm specification marker MESP1 (day 4) and the
initiation of cardiovascular lineage commitment asmarked
by the expression of NKX2-5, GATA4, and MEF2C genes
(day 9) (Den Hartogh et al., 2015).
RA + BMP4 Synergistically Promote Differentiation of
hPSCs into Proepicardial-like Cells in Monolayer
Culture
In addition to 3D hPSC differentiation in EBs, we also
examined the effect of RA + BMP4 on the induction of pro-
epicardial-like cells fromhPSCs in 2Dmonolayer culture by
adapting a protocol we recently described for simultaneous
differentiation of cardiomyocytes and endothelial cells
from common cardiac mesoderm (Giacomelli et al., 2017)
(Figure S1A and S1A0). In agreement with our previousFigure 2. Proepicardial Gene Expression in RA + BMP4-Treated NK
(A) qRT-PCR of selected gene transcripts (culture day 9) confirms in
CD31/GFP+ with respect to CD31/GFP cells (n = 4 independent exp
t test).
(B–E)WT1 and COUP-TFIImRNA expression in RA + BMP4-treated NKX2-
COUP-TFII (D and E) (red) protein expression in vitro.
(F) qRT-PCR analysis of proepicardial markers (WT1, TCF21, TBX18, and
cells (n = 5 independent experiments). Data are presented as mean ±
(G–N) CD31/GFP/PDGFRa+ are epithelial, PAN-CADHERIN+ cells.
(n = 12) results in the formation of cells aggregates showing a segregat
two cell types); CD31/GFP/PDGFRa+ cells grow over GFP+ cells (H)
epicardial markers such as WT1 (K and L) (arrowheads) and a-SMA (M)
(B)–(E), (G), and (J); 100 mm in (H), (I), (K), and (M); 10 mm in (L)
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again critical for the induction of GFP/PDGFRa+ epicar-
dial/proepicardial cells and for the upregulation of WT1
expression in 2D differentiations (Figures S1B and S1C).
Gene expression profiling revealed comparable expression
levels of epicardial/proepicardial genes (WT1, TCF21,
TBX18, and COUP-TFII) at day 9 of differentiation in all
the different hPSC lines (the NKX2-5EGFP/w hESCs and
the wild-type hiPSC lines NCRM1 and SFLB6, see Zhang
et al., 2014) used in this study (Figure 1F), indicating the
robustness of the protocol. Notably, inhibition of WNT
signaling by XAV supplementation at day 3 had little or
no effect on the differentiation of epicardial/proepicardial
cells in 2D monolayer differentiation conditions (Figures
S1A0–S1C). We also tested the effect of inhibition of WNT
signaling using cultured embryonic day 9.5 (E9.5) mouse
proepicardia in vitro. Importantly, WNT antagonist IWP2
also did not affect expression of the proepicardial genes
WT1 and COUP-TFII in these experiments (Figure S2).
CD31, GFP, and PDGFRa Expression Profiles Define
Three Cell Phenotypes after NKX2-5EGFP/w hESC
Treatment with RA + BMP4
Since cardiomyocyte differentiation from NKX2-5EGFP/w
hESCs can be monitored through GFP expression, we
refined the characterization of cell phenotypes after culture
protocol 4 in EBs (Figure 1B) using GFP as a landmark for
cardiac versus non-cardiac cell differentiation. Cells were
sorted by FACS based on their GFP and CD31 expression,
and only the CD31 fractions (non-endothelial cells)
were selected for further characterization. As expected,
cardiogenic (NKX2-5/TBX5) gene expression in CD31/
GFP cells was almost undetectable when compared with
CD31–/GFP+ cells (Figure S3A). However, the expression
of WT1, TCF21, TBX18, and COUP-TFII genes was
significantly increased in the CD31/GFP cell fraction
compared with the CD31/GFP+ population (Figure 2A),
as was the expression of other epicardial/proepicardial
genes, such as RALDH2, E-CADHERIN, and a4 INTEGRINX2-5EGFP/w hESC-Derived Cells
crease in cardiomyocyte and decrease in proepicardial markers in
eriments). Data are presented as mean ± SD (*p < 0.05 by unpaired
5EGFP/w hESCs (CD31/GFP) is paralleled by WT1 (B and C) (red) and
COUP-TFII) in CD31/GFP/PDGFRa+ versus CD31/GFP/PDGFRa
SD (*p < 0.05 by unpaired t test).
CD31/GFP/PDGFRa+ and CD31/GFP+/PDGFRa± cell co-culture
ion between GFP+ and GFP cells (white dashed lines separate these
, forming a CK+ epithelium (I and J) (arrowheads) and expressing
(arrowheads). All the cells remain CD31 (N). Scale bars, 50 mm in
; and 25 mm in (N).
(Figure S3A). Expression of COUP-TFII, an orphan nuclear
receptor critical for mesodermal differentiation into multi-
ple cell types (Xie et al., 2011), was of special interest since
it is strongly expressed by proepicardial cells but only at
relatively low levels by epicardial cells in vivo (Lin et al.,
2012). This suggests that COUP-TFII expression identifies
amore primitive set of cells in the septum transversum-pro-
epicardium-epicardium continuum (Cano et al., 2016),
and we thus refer to these cells as proepicardial/epicar-
dial-like cells.
Immunocytochemistry confirmed WT1 and COUP-TFII
nuclear protein accumulation in CD31/GFP cells, but
not in CD31/GFP+ (Figures 2B–2E), suggesting that the
identity of hESC-derived CD31/GFP cells was more
similar to epicardial progenitors (proepicardial cells) than
to epicardial cells. To precisely define the nature of
CD31/GFP cells, we sorted the cells on the basis of the
PDGFRa mesodermal/epicardial marker (Guadix et al.,
2011; Hwang et al., 2013). Our results confirmed that the
expression of the proepicardial-related genes WT1,
TCF21, TBX18, and COUP-TFII (Figure 2F) was higher in
CD31/GFP/PDGFRa+ than in CD31/GFP/PDGFRa
cells. 2D monolayer differentiation resulted in robust in-
duction of proepicardial-like cells from hPSCs without
prior need for enrichment of the PDGFRa+ population (Fig-
ure S3B). These cells also expressed typical proepicardial-
associated genes WT1, TCF21, TBX18, and COUP-TFII
(Figure S3C).
Immunocytochemical analysis of PAN-CADHERIN
expression confirmed that these cells were epithelial in
phenotype (Figure 2G), as expected for epicardial cells,
which are a subtype of visceral mesothelium. Furthermore,
proepicardial-like cells expanded from the monolayer dif-
ferentiation protocol exhibited typical cobblestone-like
morphology with nuclear localization of WT1 and COUP-
TFII (Figures S4A and S4B). We have shown that RA +
BMP4-treated NKX2-5EGFP/w hESCs mostly differentiate
into PDGFRa+/GFP non-cardiomyocyte cells, which ex-
press proepicardial genes such as WT1, TCF21, TBX18,
and COUP-TFII. However, some RA + BMP4-treated
NKX2-5EGFP/w hESCs still differentiated into PDGFRa+/
GFP+ cardiomyocytes. Further research is required to ascer-
tain whether those cardiomyocytes could secondarily
derive from PDGFRa+/GFP/TBX18+/WT1+/COUP-TFII+
proepicardial-like cells.
CD31/GFP/PDGFRa+ Cells Display Embryonic
Proepicardial-like Behavior In Vitro and In Ovo
To test the functional properties of (pro)epicardial-like
CD31/GFP/PDGFRa+ cells in vitro, NKX2-5EGFP/w hESCs
were cultured following protocol 4 (see Figure 1B).
CD31/GFP/PDGFRa+ (proepicardial), and CD31/GFP+/
PDGFRa± (myocardial) cell populations were sorted at day9 of differentiation (D9, see Figure 1B), and then mixed
(1:1) to form aggregates in vitro. At day 13 of differentiation,
two different cell phases were evident in the aggregates,
only one of them expressing GFP (Figure 2H). Immunohis-
tochemical analysis of the aggregates (Figures 2I and 2J)
identified cytokeratin (CK) (an epithelial intermediate
filament) in the CD31/GFP/PDGFRa+ cell population,
which also expressedWT1 (Figures 2K and 2L), and smooth
muscle-specific a-actin (a-SMA) (Figure 2M), but remained
CD31 (Figure 2N). The characteristic distribution of some
CD31/GFP/PDGFRa+/CK+ cells over the surface of the
structure suggested that this cell population had grown
and spread over theCD31/GFP+/PDGFRa± cells (Figure 2J),
recapitulating normal proepicardial cell growth over the
embryonic myocardium to form the primitive epicardium.
Previous studies indicated that epicardial a4b1 integrin
(or VLA-4) plays a pivotal role in migration and adhesion
to the heart (Yang et al., 1995). Therefore, we utilized a
small-molecule a4b1 antagonist (BIO5192) to confirm the
importance of this interaction for the formation of
in vitro aggregates. BIO5192-treated aggregates displayed a
marked disruption of proepicardial-like CD31/GFP/
PDGFRa+ cell aggregation with the cells dispersing in the
culture, while myocardial CD31/GFP+/PDGFRa± cells re-
mained as a coherent cell mass in control and BIO5192-
treated aggregates (Figure S4C).
Functional properties of CD31/GFP/PDGFRa+ cells
were also tested in ovo. RA + BMP4-treated NKX2-5EGFP/w
hESC EBs (6 days of culture, protocol 4) were grafted into
chick embryo hosts (HH17) (Figure 3A). After 7 days, these
EBs were identified by their expression of a human pan-nu-
clear (hNu) marker (Figures 3B–3D). Some of the donor EBs
were attached to, and partially spread over, the myocardial
surface (Figures 3C and 3D). Groups of grafted cells
migrated into the myocardial layers (Figure 3D). The outer
surface of the EBs was covered by CK-expressing epithelial
cells (Figure 3E). All cells in the EBs expressed the hNu an-
tigen (Figure 3F), while only some expressed the proepicar-
dial markers COUP-TFII (Figure 3G) andWT1 (Figure S4D).
No GFP+ cells were detected in the hostmyocardium at any
time (Figure S4D). COUP-TFII+ cells were located in the in-
ner layers of the EBs (Figure 3H) or in their epithelial surface
(Figure 3I); in both cases the cells expressed the epithelial
marker CK (Figures 3H and 3I). Groups of hNu+ cells on
the surface and inside the EBs expressed the a-SMA marker
(Figures 3J–3M); some of these a-SMA+ cells were able to
invade the myocardium (Figures 3L and 3M). In addition,
we examined the in ovo functional properties of proepicar-
dial-like cells derived from the optimized 2D monolayer
differentiation protocol (RA + BMP4) (Figure S1A). For
this, expanded hiPSC-derived proepicardial-like cells were
counterstained with the CMTPX CellTracker Red and sub-
sequently injected as cell suspensions into the prospectiveStem Cell Reports j Vol. 9 j 1754–1764 j December 12, 2017 1759
(legend on next page)
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pericardial cavity of Hamburger-Hamilton stage 16–17
chick embryos (Figure 3N). Both the hESC-derived (Figures
3O–3Q) and hiPSC-derived proepicardial-like cells (Figures
3R–3U) attached and spread over the myocardial surface.
Some of these cells expressed the WT1 protein (Figures
3Q and 3U) andwere found to invade themyocardial layers
(Figures 3Q, 3T, and 3U). These results differ from those
published previously (Iyer et al., 2015), which reported
the presence of intravascularly injected hESC-derived cells
in the subepicardial space and the walls of coronary ar-
teries, but not in the epicardial epithelium itself. Our
finding that hPSC-derived CD31/GFP/PDGFRa+ cells
can form an epicardial-like epithelial envelope over the
chick host myocardium confirms that these cells possess
critical morphogenetic properties of epicardial progenitor
cells, although the extent of hPSC-derived proepicardial-
like cell migration over the chick myocardium is likely to
be limited by intrinsic differences between the host and
the donor.
In this work we have shown that RA + BMP4-treated
hPSCs can differentiate into mesodermal cells displaying
a gene expression profile and functional properties of pro-
epicardial cells, a subpopulation of the lateral plate meso-
derm that accumulates at the venous (posterior) pole of
the embryonic heart and is essential during heart embryo-
genesis (Pérez-Pomares and de la Pompa, 2011). Proepicar-
dial cells have been hypothesized to be multipotent
(Wessels and Pérez-Pomares, 2004), as they can differen-
tiate into epicardial epithelial cells, endothelium, smooth
muscle cells, fibroblasts, and cardiomyocytes (Brade et al.,
2013) under different in vivo and/or in vitro conditions.
Interestingly, the combined, persistent expression of
PDGFRa and COUP-TFII in a proportion of hPSC-derived
CD31/GFP cells suggests they still retain multipotency
associated with subpopulations of the primitive lateral
mesoderm including the proepicardium (Chong et al.,
2011; Lin et al., 2012), as summarized in Figure 4.Figure 3. Functional Properties of CD31/GFP/PDGFRa+ Cells
NKX2-5EGFP/w hESC-derived EBs (arrow) treated under protocol 4 were
experiments). Some EBs attach to the myocardium of HH17 chick host
over the myocardium (C and D) (arrows) or migrate into the myocard
marker CK (E) (green). COUP-TFII expression in EB cells is conspicu
cytokeratin both inside (H) (arrows) and on the surface of EBs (H a
arrowheads in (J) and (K); the area marked by the asterisk in (J) is mag
in (L) and (M) and the dashed line in (L) mark the border between the E
like cells were stained with CellTracker Red and injected into the per
n = 10 independent experiments; SFLB6, n = 10 independent exp
attached to the myocardium (cTnT, green tissue) of HH17 chick host (
(P, Q, T, and U) (arrows) and some other cells migrated into the myoc
a human nuclear-specific marker (hNuclei) (P and T) (white). WT1 ex
(U) (green). EB, embryoid body; H, heart; Myo, myocardium. Scale bar
(F), (G), (O), (Q), (S), (T), and (U); 10 mm in (I); 100 mm in (J) andWe conclude that our cell culture protocol is a rapid and
robust method for generating proepicardial (epicardial pro-
genitor)-like cells in both aggregates and monolayer cul-
tures with intrinsic cardiomyogenic potential that can be
further manipulated. This cell platform could be relevant
for the study of cell and molecular pathophysiological
mechanisms underlying different cardiovascular diseases,
and could also facilitate stem cell-based therapies to regen-
erate and repair injured cardiac tissues.EXPERIMENTAL PROCEDURES
hESC Culture and Differentiation to Cardiomyocytes
and Epicardial-like Cells
Undifferentiated NKX2-5EGFP/w hESCs were cultured as described
in the Supplemental Information. BMP4 and RA concentrations
used have been previously tested in other studies onhESC differen-
tiation into mesodermal cells and cardiogenic progenitors (Birket
et al., 2015; Devalla et al., 2015).
Monolayer Differentiation of hPSCs to Epicardial-like
Cells
Cardiac mesoderm was induced in monolayer culture as described
previously (Giacomelli et al., 2017). The following hPSC lines were
used: NKX2-5EGFP/w hESCs and two control hiPSC lines SFLB6
(Zhang et al., 2014) and NCRM1 (NIH Center for Regenerative
Medicine [NIH CRM]), obtained from RUDCR Infinite Biologics
at Rutgers University. For hPSC-derived cardiomyocyte differ-
entiation BPEL medium (BSA polyvinyl alcohol essential lipids
[Ng et al., 2008]) supplemented with a mixture of cytokines was
used (see Supplemental Information).
Flow Cytometry (FACS) and Cell Sorting
On day 9 of differentiation, EBs or monolayers were dissociated
using TrypLE Select 13 (Gibco), washed once with FACS buffer
containing 10% fetal bovine serum, and washed again in FACS
buffer (Ca2+- and Mg2+-free PBS plus 0.5% BSA, 2 mM EDTA).
Cells were analyzed with the MACSQuant VYB cytometergrafted into chick embryos as shown in (A) (n = 10 independent
hearts (B) (arrow), the graft is magnified in (B0); donor cells spread
ium (C) (arrowheads). Cells in the EB surface express the epithelial
ous (F and G) (arrowheads in G); some COUP-TFII+ cells express
nd I) (arrowheads). Many cells at the EB surface express a-SMA,
nified in (K); some a-SMA+ cells invade the myocardium; arrowheads
B and the host myocardium. hPSC-derived proepicardial/epicardial-
icardial cavity of chick embryo hearts as shown (N) (NKX2-5EGFP/w,
eriments). Some proepicardial/epicardial-like cells (red staining)
arrows in O, R, and S); some donor cells spread over the myocardium
ardium (Q, T, and U) (arrowheads). CellTracker Red+ cells expressed
pression is also conspicuous in human donor cells (Q) (white) and
s, 500 mm in (B); 25 mm in (C), (D), (E), (H), (K), and (L); 50 mm in
(P); 15 mm in (M); and 200 mm in (R).
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Figure 4. The Proepicardium and the
Lateral Plate Mesoderm
Blastodermal derivatives in E8.5 (A–C) and
E9.5–E10.0 (C–G) mouse embryos. WT1 (F)
(green) is expressed in the majority of
splanchnic lateral mesodermal cells,
including the proepicardium (PRO), the
primitive epicardium (EP), and the pericar-
dium (PE). On the contrary, COUP-TFII
expression (F) (red) is strong in cardiac
inflow myocardial progenitors (asterisks),
proepicardial cells (PRO), but not epicardial
(EP) or pericardial (PE) cells. Scale bars,
200 mm in (F) and 10 mm in (G)–(G00).(Miltenyi) and sorted on FACSAria III flow cell sorter (BD
Biosciences) using antibodies as listed in the Supplemental
Information.
Gene Expression Analysis
Extraction of RNA from EB samples (protocols 1–4, day 9 of cul-
ture) was performed using the RNeasy-Micro Kit (QIAGEN),
whereas the NucleoSpin RNA XS Kit (MACHEREY-NAGEL) was
used in sorted cell populations and monolayer cultures. RNA was
submitted to reverse transcription to obtain cDNA (1 mg) using
the Iscript cDNA Kit (Bio-Rad). For details on the full procedure
and primers used see the Supplemental Information and Table S1.
Immunocytochemistry
Cell pools were sorted according to their cell surface expression
profile (CD31; GFP; PDGFRa) and grown in regular BPEL medium.
After 6 days of culture, cells were fixed in 4% paraformaldehyde
and processed for immunohistochemistry as described in the
Supplemental Information.
EB In Ovo Transplantations
NKX2-5EGFP/w hESC-derived EBs were generated using protocol 4
(RA + BMP4; Figure 1A), cultured for 7 days, and grafted into the
prospective pericardial cavity of HH16-17 chick embryos. Twelve
transplantations were performed; only ten grafts (those attached
to the myocardium) were analyzed.
hPSC In Ovo Transplantation
NKX2-5EGFP/w hESCs and SFLB6 hiPSCs were differentiated and
cultured using a monolayer differentiation protocol (Figure S1A).
Differentiated cells were sorted and PDGFRa± cells were expanded,
stained with CellTracker Red, and then injected into the prospec-
tive pericardial cavity of HH16-17 chick embryos. Donor hearts1762 Stem Cell Reports j Vol. 9 j 1754–1764 j December 12, 2017were directly examined under a fluorescence dissecting scope
and further characterized by immunohistochemistry. The full pro-
tocol is available in the Supplemental Information.
Culture of Cell Aggregates
NKX2-5EGFP/w hESCs from protocol 4 (RA + BMP4; Figure 1A) were
used to form cell spheroids. Cells were selected and cultured as
described in the Supplemental Information.
Statistical Analysis
Statistical significance was assessed by Student’s t test (comparison
of two groups) or one-way ANOVA with Tukey’s multiple compar-
ison test (comparison of four groups). Significance by Student’s
t test was attributed to comparisons with values of p < 0.05. All
error bars represent SD.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and two tables and can be found
with this article online at https://doi.org/10.1016/j.stemcr.2017.
10.023.
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